DE602004017220D1 - Mikrokristall und medizinische zusammensetzung, die diesen enthält - Google Patents

Mikrokristall und medizinische zusammensetzung, die diesen enthält

Info

Publication number
DE602004017220D1
DE602004017220D1 DE602004017220T DE602004017220T DE602004017220D1 DE 602004017220 D1 DE602004017220 D1 DE 602004017220D1 DE 602004017220 T DE602004017220 T DE 602004017220T DE 602004017220 T DE602004017220 T DE 602004017220T DE 602004017220 D1 DE602004017220 D1 DE 602004017220D1
Authority
DE
Germany
Prior art keywords
micro
crystal
composition containing
medical composition
microcrystals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004017220T
Other languages
German (de)
English (en)
Inventor
Naoto Izawa
Norie Satoh
Nobuhiro Yagi
Kazue Ouchi
Shoichi Narita
Noboru Aoki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of DE602004017220D1 publication Critical patent/DE602004017220D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
DE602004017220T 2003-12-11 2004-12-09 Mikrokristall und medizinische zusammensetzung, die diesen enthält Expired - Fee Related DE602004017220D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003413725 2003-12-11
PCT/JP2004/018773 WO2005056561A1 (ja) 2003-12-11 2004-12-09 微細結晶及びそれを含む医薬製剤

Publications (1)

Publication Number Publication Date
DE602004017220D1 true DE602004017220D1 (de) 2008-11-27

Family

ID=34675069

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004017220T Expired - Fee Related DE602004017220D1 (de) 2003-12-11 2004-12-09 Mikrokristall und medizinische zusammensetzung, die diesen enthält

Country Status (13)

Country Link
US (1) US20070049634A1 (zh)
EP (1) EP1693374B1 (zh)
JP (1) JPWO2005056561A1 (zh)
KR (1) KR20060121163A (zh)
CN (1) CN1845927A (zh)
AT (1) ATE411320T1 (zh)
AU (1) AU2004297132A1 (zh)
CA (1) CA2550136A1 (zh)
DE (1) DE602004017220D1 (zh)
ES (1) ES2314484T3 (zh)
NO (1) NO20063134L (zh)
TW (1) TW200522943A (zh)
WO (1) WO2005056561A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190314220A1 (en) 2018-04-11 2019-10-17 The Procter & Gamble Company Disposable Absorbent Articles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3283267B2 (ja) * 1997-04-15 2002-05-20 協和醗酵工業株式会社 三環式化合物
WO2000000492A1 (fr) * 1998-06-26 2000-01-06 Chugai Seiyaku Kabushiki Kaisha DERIVE D'ACIDE L-α-AMINOADIPIQUE EN POUDRE FINE, PREPARATIONS SOLIDES ORALES CONTENANT LEDIT DERIVE ET PROCEDE DE TRAITEMENT DE POUDRES EN VRAC
JP2002053580A (ja) * 2000-08-09 2002-02-19 Kyowa Hakko Kogyo Co Ltd 三環系化合物の製造法
WO2002013823A1 (en) * 2000-08-14 2002-02-21 Teva Pharmaceutical Industries Ltd. Micronized torsemide
AU2002239504A1 (en) * 2000-12-06 2002-06-18 Pharmacia Corporation Laboratory scale milling process
CN1498109A (zh) * 2001-03-30 2004-05-19 Э�ͷ��͹�ҵ��ʽ���� 膀胱感觉过敏治疗剂
US7354949B2 (en) * 2001-03-30 2008-04-08 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia
CA2442463A1 (en) * 2001-03-30 2002-10-10 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for overactive bladder
US20040248926A1 (en) * 2001-11-13 2004-12-09 Hayashi Ken-Ichi Preventive or remedy for pruritus

Also Published As

Publication number Publication date
CA2550136A1 (en) 2005-06-23
US20070049634A1 (en) 2007-03-01
CN1845927A (zh) 2006-10-11
WO2005056561A1 (ja) 2005-06-23
EP1693374A4 (en) 2007-01-03
KR20060121163A (ko) 2006-11-28
EP1693374A1 (en) 2006-08-23
ATE411320T1 (de) 2008-10-15
EP1693374B1 (en) 2008-10-15
ES2314484T3 (es) 2009-03-16
AU2004297132A1 (en) 2005-06-23
TW200522943A (en) 2005-07-16
NO20063134L (no) 2006-09-08
JPWO2005056561A1 (ja) 2007-07-05

Similar Documents

Publication Publication Date Title
DE60228761D1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
AU2003211560A1 (en) Novel phenylalanine derivative
EP2085096A3 (en) Novel composition and methods for the treatment of immune related diseases
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
WO2005094785A3 (en) Compositions capable of facilitating penetration across a biological barrier
EP1420785A4 (en) SUBSTITUTED INDONO 1,2-C] ISOQUINOLINE DERIVATIVES AND METHODS OF USING THE SAME
IL216579A0 (en) Aminocyclohexyl ether derivatives and pharmaceutical compositions containing the same
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
WO2003095455A3 (en) Substituted pyrazolopyrimidines
AU2002323946A1 (en) External preparation
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
WO2004091591A3 (fr) Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
WO2005054172A3 (en) Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof
CY1105939T1 (el) Παραγωγα βενζοθειαζινης και βενζοθεαδιαζινης, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τα πepιεχουν
IL172408A0 (en) Use of bicyclo[2.2.1] heptane derivatives for the preparation of neuroprotective pharmaceutical compositions
WO2003020963A3 (en) Proteins in type 2 diabetes
WO2003015780A8 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
WO2003022844A3 (en) Synthesis of epothilones intermediates thereto and analogues thereof
BRPI0408423A (pt) composições farmacêuticas compreendendo uma combinação de rapamicina ou seus derivados e pimecrolimus para o tratamento de doenças mediadas imunologicamente e por inflamação
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
WO2004024077A3 (en) Novel composition and methods for the treatment of psoriasis
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
DE602004017220D1 (de) Mikrokristall und medizinische zusammensetzung, die diesen enthält
WO2004056832A3 (en) Epothilone derivatives
AU2002342498A1 (en) Organic compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee